FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sophie Matheron

Research Profile

Disorders

Living Beings

Concepts & Ideas

Procedures

Chemicals & Drugs

Geographic Areas

France

Physiology

Co-author Network

Publications

TOP 3
Benoit Visseaux; Antoine Bénard; Françoise Brun-Vézinet; Charlotte Charpentier; Geneviève Chêne; Florence Damond; Diane Descamps; Lucile Larrouy; Sophie Matheron; Audrey Taieb
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
Lucile Larrouy; Sophie Matheron; Benoit Visseaux; Alexandre Vivot; Antoine Bénard; Françoise Brun Vezinet; Charlotte Charpentier; Geneviève Chene; Florence Damond; Diane Descamps
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
Rodolphe Thiébaut; Romain Antoine; Françoise Brun-Vézinet; Jacqueline Capeau; Charlotte Charpentier; Geneviève Chêne; Gilles Collin; Florence Damond; Diane Descamps; Sophie Matheron; Audrey Taieb
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sophie Matheron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Benoit Visseaux; Antoine Bénard; Françoise Brun-Vézinet; Charlotte Charpentier; Geneviève Chêne; Florence Damond; Diane Descamps; Lucile Larrouy; Sophie Matheron; Audrey Taieb
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013;27(2):292-5.
2013: Lucile Larrouy; Sophie Matheron; Benoit Visseaux; Alexandre Vivot; Antoine Bénard; Françoise Brun Vezinet; Charlotte Charpentier; Geneviève Chene; Florence Damond; Diane Descamps
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
AIDS (London, England) 2013;27(1):69-80.
2012: Rodolphe Thiébaut; Romain Antoine; Françoise Brun-Vézinet; Jacqueline Capeau; Charlotte Charpentier; Geneviève Chêne; Gilles Collin; Florence Damond; Diane Descamps; Sophie Matheron; Audrey Taieb
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(10):1417-25.
2012: Sandrine Cojean; Djamel Haouchine; Sandrine Houzé; Véronique Hubert; Françoise Huteau; Sylvie Lariven; Jacques Le Bras; Philippe Marie Loiseau; Florence Michard; Francine Pratlong; Christian Bories; Sophie Matheron
Leishmania resistance to miltefosine associated with genetic marker.
Emerging infectious diseases 2012;18(4):704-6.
2012: Benoit Visseaux; Françoise Brun-Vézinet; Charlotte Charpentier; Gilles Collin; Florence Damond; Diane Descamps; Margarita Hurtado-Nedelec; Lucile Larrouy; Sophie Matheron; Alexandre Storto
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of infectious diseases 2012;205(1):111-20.
2012: Benoit Visseaux; Romain Antoine; Françoise Brun-Vézinet; Charlotte Charpentier; Florence Damond; Diane Descamps; Margarita Hurtado-Nedelec; Sophie Matheron; Gilles Peytavin; Alexandre Storto
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial agents and chemotherapy 2012;56(1):137-9.
2011: Florence Damond; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Sophie Matheron; Berta Rodes; Jean Ruelle; Vicente Soriano; Audrey Taieb; Mark Wainberg; Claudia Balotta; Antoine Benard; Jürg Böni; Françoise Brun Vezinet; Geneviève Chene; Matthew Cotten
An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.
Journal of clinical microbiology 2011;49(10):3491-7.
2011: Charlotte Charpentier; Bénédicte Roquebert; Olivier Delelis; Lucile Larrouy; Sophie Matheron; Roland Tubiana; Marina Karmochkine; Xavier Duval; Geneviève Chêne; Alexandre Storto; Gilles Collin; Antoine Bénard; Florence Damond; Jean-François Mouscadet; Françoise Brun-Vézinet; Diane Descamps
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.
Antimicrobial agents and chemotherapy 2011;55(3):1293-5.
2011: Charlotte Charpentier; Geneviève Chêne; Florence Damond; Olivier Delelis; Diane Descamps; Lucile Larrouy; Sophie Matheron; Jean-François Mouscadet; Françoise Brun-Vézinet; Pauline Campa
Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.
Antiviral therapy 2011;16(6):937-40.
2008: Florence Damond; Antoine Benard; Jean Ruelle; Abraham Alabi; Bernd Kupfer; Perpetua Gomes; Berta Rodes; Jan Albert; Jürg Böni; Jeremy Garson; Bridget Ferns; Sophie Matheron; Geneviève Chene; Françoise Brun Vezinet
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.
Journal of clinical microbiology 2008;46(6):2088-91.
2008: Delphine Desbois; Bénédicte Roquebert; Gilles Peytavin; Florence Damond; Gilles Collin; Antoine Bénard; Pauline Campa; Sophie Matheron; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.
Antimicrobial agents and chemotherapy 2008;52(4):1545-8.
2008: Florence Damond; Sylvie Lariven; Benedicte Roquebert; Sylvia Males; Gilles Peytavin; Genevieve Morau; Daniel Toledano; Diane Descamps; Françoise Brun Vezinet; Sophie Matheron
Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.
AIDS (London, England) 2008;22(5):665-6.
2008: Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.
AIDS (London, England) 2008;22(4):457-68.
2008: Eric D'Ortenzio; Nadine Godineau; Arnaud Fontanet; Sandrine Houze; Olivier Bouchaud; Sophie Matheron; Jacques Le Bras
Prolonged Plasmodium falciparum infection in immigrants, Paris.
Emerging infectious diseases 2008;14(2):323-6.
2008: Hana Selinger-Leneman; Sophie Matheron; Aba Mahamat; Jacques Moreau; Dominique Costagliola; Sophie Abgrall
Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):206-11.
2008: Marie Gueudin; Florence Damond; Joséphine Braun; Audrey Taïeb; Véronique Lemée; Jean-Christophe Plantier; Geneviève Chêne; Sophie Matheron; Françoise Brun-Vézinet; François SIMON
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
AIDS (London, England) 2008;22(2):211-5.
2007: D Lemly; Laurent Mandelbrot; F Meier; Ghislaine Firtion; Sophie Matheron; V Jeantils; T A Scott
Factors related to medical appointment attendance after childbirth among HIV-infected women in the Paris region.
AIDS care 2007;19(3):346-54.
2006: Vincent Peigne; Olivier Lidove; Maria Chauchard; Antoine Rousseau; Laurence Choudat; Aurélie Fabre; Sandrine Houzé; Jean-Pierre Trinh-Khac; Sylvia Males; Sophie Matheron; Thomas Papo
[Histoplasmosis leading to diagnosis of HIV infection].
Presse médicale (Paris, France : 1983) 2006;35(12 Pt 1):1849-50.
2006: Valérie Briand; Pierre A Buffet; Sabine Genty; Karine Lacombe; Nadine Godineau; Jérome Salomon; Eric Vandemelbrouck; Pascal Ralaimazava; Catherine Goujon; Sophie Matheron; Arnaud Fontanet; Olivier Bouchaud
Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1170-5.
2006: Lise Musset; Olivier Bouchaud; Sophie Matheron; Laurent Massias; Jacques Le Bras
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Microbes and infection / Institut Pasteur 2006;8(11):2599-604.
2006: Diane Descamps; Florence Damond; Antoine Bénard; Sophie Matheron; Pauline Campa; Audrey Taieb; Réda Yahyaoui; Geneviève Chêne; Françoise Brun-Vézinet
No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort.
AIDS (London, England) 2006;20(7):1076-9.
2006: A Rodrigues; P Faucher; A Batallan; L Allal; S Legac; Sophie Matheron; Patrick Madelenat
[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Gynécologie, obstétrique & fertilité 2006;34(4):304-11.
2006: Sophie Matheron; Florence Damond; Antoine Benard; Audrey Taieb; Pauline Campa; Gilles Peytavin; Sophie Pueyo; Françoise Brun Vezinet; Geneviève Chene
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort.
AIDS (London, England) 2006;20(3):459-62.
2006: Nadia Alatrakchi; Florence Damond; Sophie Matheron; Sophie Beretta-Tempelhoff; Pauline Campa; Guislaine Carcelain; Françoise Brun Vezinet; Brigitte Autran
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
AIDS (London, England) 2006;20(1):29-34.
2005: Florence Damond; Gilles Collin; Diane Descamps; Sophie Matheron; Sophie Pueyo; Audrey Taieb; Pauline Campa; Antoine Benard; Geneviève Chêne; Françoise Brun Vezinet
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.
Journal of clinical microbiology 2005;43(8):4234-6.
2005: Florence Damond; Gilles Collin; Sophie Matheron; Gilles Peytavin; Pauline Campa; Séverine Delarue; Audrey Taieb; Antoine Bénard; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene.
Antiviral therapy 2005;10(7):861-5.
2005: Florence Damond; Françoise Brun Vezinet; Sophie Matheron; Gilles Peytavin; Pauline Campa; Sophie Pueyo; Fabrizio Mammano; STEPHANE LASTERE; Isabelle Farfara; François SIMON; Geneviève Chene; Diane Descamps
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.
Journal of clinical microbiology 2005;43(1):484-7.
2004: Diane Descamps; Florence Damond; Sophie Matheron; Gilles Collin; Pauline Campa; Séverine Delarue; Sophie Pueyo; Geneviève Chêne; Françoise Brun-Vézinet
High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.
Journal of medical virology 2004;74(2):197-201.
2004: Florence Damond; Sophie Matheron; Gilles Peytavin; Pauline Campa; Audrey Taieb; Gilles Collin; Christophe Delaunay; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.
Antiviral therapy 2004;9(4):635-6.
2004: Florence Damond; Michael Worobey; Pauline Campa; Isabelle Farfara; Gilles Colin; Sophie Matheron; Françoise Brun-Vézinet; David L Robertson; François SIMON
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification.
AIDS research and human retroviruses 2004;20(6):666-72.
2003: Sophie Matheron; Sophie Pueyo; Florence Damond; François SIMON; Annie Leprêtre; Pauline Campa; Roger Salamon; Geneviève Chêne; Françoise Brun Vezinet
Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.
AIDS (London, England) 2003;17(18):2593-601.
2003: Sophie Abgrall; Xavier Duval; Véronique Joly; Diane Descamps; Sophie Matheron; Dominique Costagliola
Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(11):1517-26.
2003: Isabelle Kousignian; Sophie Abgrall; Xavier Duval; Diane Descamps; Sophie Matheron; Dominique Costagliola
Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34(1):50-7.
2003: Sophie Matheron; Diane Descamps; François Boué; Jean-Michel Livrozet; Alain Lafeuillade; Christian Aquilina; Didier Troisvallets; Agnès Goetschel; Françoise Brun Vezinet; Jean-Philippe Mamet; Cécile Thiaux
Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
Antiviral therapy 2003;8(2):163-71.
2003: Marie-Christine Mazeron; Anne-Marie Fillet; Dominique Salmon; Narjis Boukli; Nadhira Houhou; Brigitte Sénéchal; Sophie Matheron; joel gozlan; Catherine Leport; Christine Katlama; Catherine Scieux; Berthe-Marie Imbert; Paul Deny; Jean-Baptiste Bour; François Freymuth; Bruno Chanzy; Sophie Chaput; Dominique Costagliola
Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2003;17(5):784-6.
2003: Karine Gourlain; Dominique Salmon; Elyanne Gault; Catherine Leport; Christine Katlama; Sophie Matheron; Dominique Costagliola; Marie-Christine Mazeron; Anne-Marie Fillet
Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Journal of medical virology 2003;69(3):401-7.
2002: Florence Damond; Marie Gueudin; Sophie Pueyo; Isabelle Farfara; David L Robertson; Diane Descamps; Geneviève Chène; Sophie Matheron; Pauline Campa; Françoise Brun-Vézinet; François SIMON
Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.
Journal of clinical microbiology 2002;40(10):3654-9.
2002: Vincent Calvez; Dominique Costagliola; Diane Descamps; Anne Yvon; Gilles Collin; Agnès Cécile; Constance Delaugerre; Florence Damond; Anne-Geneviève Marcelin; Sophie Matheron; Anne Simon; Marc-Antoine Valantin; Christine Katlama; Françoise Brun-Vézinet
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Antiviral therapy 2002;7(3):211-8.
2002: Laurence Gérard; Lionel Galicier; Anne Maillard; Emmanuelle Boulanger; Laurent Quint; Sophie Matheron; Bernard Cardon; Véronique Meignin; Eric Oksenhendler
Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival.
Journal of acquired immune deficiency syndromes (1999) 2002;30(5):478-84.
2002: Jacob P Lalezari; Janette Lindley; Sharon Walmsley; Baruch Kuppermann; Martin Fisher; Dorothy N Friedberg; Richard Lalonde; Sophie Matheron; Leopoldo Nieto; Francesca J Torriani; Rod Van Syoc; Mary Ann Sutton; William C Buhles; Mary Jean Stempien
A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
Journal of acquired immune deficiency syndromes (1999) 2002;30(4):392-400.
2002: Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Ester Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.
AIDS (London, England) 2002;16(5):727-36.
2001: Florence Damond; Diane Descamps; Isabelle Farfara; J N Telles; S Puyeo; Pauline Campa; Annie Leprêtre; Sophie Matheron; Françoise Brun Vezinet; François SIMON
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.
Journal of clinical microbiology 2001;39(12):4264-8.
2001: Mireille Mouroux; Diane Descamps; Jacques Izopet; Anne Yvon; Constance Delaugerre; Sophie Matheron; A Coutellier; Marc-Antoine Valantin; Manuela Bonmarchand; Henri Agut; P Massip; Dominique Costagliola; Christine Katlama; Françoise Brun Vezinet; Vincent Calvez
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Antiviral therapy 2001;6(3):179-83.
2001: Jacques Gasnault; P Kousignian; M Kahraman; J Rahoiljaon; Sophie Matheron; Jean-François Delfraissy; Yassine Taoufik
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Journal of neurovirology 2001;7(4):375-81.
2001: P Faucher; A Batallan; H Bastian; Sophie Matheron; G Morau; Patrick Madelenat; Jean-Louis Benifla
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies].
Gynécologie, obstétrique & fertilité 2001;29(3):211-25.
2001: Sophie Abgrall; Sophie Matheron; V Le Moing; C Dupont; Dominique Costagliola
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
Journal of acquired immune deficiency syndromes (1999) 2001;26(2):151-8.
2001: Florence Damond; Cristian Apetrei; David L Robertson; Sandrine Souquière; Annie Leprêtre; Sophie Matheron; Jean-Christophe Plantier; Françoise Brun-Vézinet; François SIMON
Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Virology 2001;280(1):19-30.
2000: Mireille Mouroux; Jacques Izopet; Diane Descamps; Constance Delaugerre; A Yvon-Groussin; F Angleraud; A Coutellier; Manuela Bonmarchand; Marc-Antoine Valantin; Sophie Matheron; Henri Agut; Christine Katlama; Françoise Brun Vezinet; Vincent Calvez
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T].
Pathologie-biologie 2000;48(5):508-12.
2000: Dominique Salmon-Céron; Marie-Christine Mazeron; Sophie Chaput; Narjis Boukli; B Senechal; Nadhira Houhou; Christine Katlama; Sophie Matheron; Anne-Marie Fillet; joel gozlan; Catherine Leport; V Jeantils; François Freymuth; Dominique Costagliola
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2000;14(8):1041-9.
2000: F Bouscarat; E Maubec; Sophie Matheron; V Descamps
Immune recovery inflammatory folliculitis.
AIDS (London, England) 2000;14(5):617-8.
2000: B M Anduze-Faris; Anne-Marie Fillet; joel gozlan; R Lancar; Narjis Boukli; Jacques Gasnault; E Caumes; J Livartowsky; Sophie Matheron; Catherine Leport; Dominique Salmon; Dominique Costagliola; Christine Katlama
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients.
AIDS (London, England) 2000;14(5):517-24.
1999: F Bouscarat; M Levacher; MC Dazza; F Chau; B Desforges; M Muffat-Joly; Sophie Matheron; Pierre-Marie Girard; Martine Sinet
Prospective study of CD8+ lymphocyte activation in relation to viral load in HIV-infected patients with > or = 400 CD4+ lymphocytes per microliter.
AIDS research and human retroviruses 1999;15(16):1419-25.
1999: Laurent Mandelbrot; Marianne Burgard; Jean Paul Teglas; JL Bénifla; C Khan; P Blot; E Vilmer; Sophie Matheron; Ghislaine Firtion; Stéphane Blanche; Marie-Jeanne Mayaux; Christine Rouzioux
Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers.
AIDS (London, England) 1999;13(15):2143-9.
1998: I Cochereau; N Belayachi; C Diraison; Sophie Matheron; I Bouyer; Thanh Hoang-Xuan; A G Saimot; J P Coulaud
[Treatment of CMV retinitis with intravitreal foscarnet].
Journal français d'ophtalmologie 1998;21(10):723-6.
1998: Christine Katlama; Marc-Antoine Valantin; Sophie Matheron; A Coutellier; Vincent Calvez; Diane Descamps; C Longuet; Manuela Bonmarchand; Roland Tubiana; Marcio De-Sa; R Lancar; Henri Agut; Françoise Brun Vezinet; Dominique Costagliola
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
Annals of internal medicine 1998;129(7):525-31.
1998: Diane Descamps; Vincent Calvez; Gilles Collin; A Cécille; Cristian Apetrei; Florence Damond; C Katlama; Sophie Matheron; J M Huraux; Françoise Brun-Vézinet
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.
Journal of clinical microbiology 1998;36(7):2143-5.
1998: C Darras-Joly; Jean-Christophe Lucet; Jean-Pierre Laissy; C Chochillon; Enrique Casalino; Véronique Joly; Sophie Matheron; Elisabeth Bouvet
[Invasive pulmonary aspergillosis in AIDS].
Pathologie-biologie 1998;46(6):416-7.
1998: Florence Damond; I Loussert-Ajaka; Cristian Apetrei; Diane Descamps; Sandrine Souquière; Annie Leprêtre; Sophie Matheron; Françoise Brun-Vézinet; François SIMON
Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA.
Journal of clinical microbiology 1998;36(3):809-11.
1997: Marie-Jeanne Mayaux; Jean Paul Teglas; Laurent Mandelbrot; A Berrebi; H Gallais; Sophie Matheron; Nicole Ciraru-Vigneron; F Parnet-Mathieu; A Bongain; Christine Rouzioux; Jean-François Delfraissy; Stéphane Blanche
Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.
The Journal of pediatrics 1997;131(6):857-62.
1997: I Loussert-Ajaka; L Mandelbrot; MC Delmas; H Bastian; Jean-Louis Benifla; Isabelle Farfara; I De Vincenzi; Sophie Matheron; François SIMON; Françoise Brun Vezinet
HIV-1 detection in cervicovaginal secretions during pregnancy.
AIDS (London, England) 1997;11(13):1575-81.
1997: Sophie Matheron; G Mendoza-Sassi; F Simon; R Olivares; J P Coulaud; Françoise Brun Vezinet
HIV-1 and HIV-2 AIDS in African patients living in Paris.
AIDS (London, England) 1997;11(7):934-6.
1996: C Darras-Joly; S Chevret; Michel Wolff; Sophie Matheron; Pascale Longuet; Enrique Casalino; Véronique Joly; C Chochillon; Jean-Pierre Bédos
Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(2):369-76.
1995: I Cochereau; Jean-François Korobelnik; E Petit; Sophie Matheron; Pascale Longuet; Thanh Hoang-Xuan
[Prognosis of retinal detachment in cytomegalovirus retinitis].
Journal français d'ophtalmologie 1995;18(10):603-7.
1995: C Tamalet; François SIMON; C Dhiver; Sophie Matheron; P de Micco; J A Gastao; F Brun-Vézinet
Autologous neutralizing antibodies and viral load in HIV-2-infected individuals.
AIDS (London, England) 1995;9(1):90-1.
1993: François SIMON; Sophie Matheron; C Tamalet; I Loussert-Ajaka; S Bartczak; J M Pépin; C Dhiver; E Gamba; C Elbim; J A Gastaut
Cellular and plasma viral load in patients infected with HIV-2.
AIDS (London, England) 1993;7(11):1411-7.
1993: Jean-Claude Melchior; G Raguin; A Boulier; Elisabeth Bouvet; D Rigaud; Sophie Matheron; Enrique Casalino; J L Vilde; François Vachon; J P Coulaud
Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections.
The American journal of clinical nutrition 1993;57(5):614-9.
1992: Jean-Pierre Bédos; C Hignette; Jean-Christophe Lucet; B Kilani; Enrique Casalino; Michel Wolff; Sophie Matheron; C Leport; François Vachon
Serum carcinoembryonic antigen: a prognostic marker in HIV-related Pneumocystis carinii pneumonia.
Scandinavian journal of infectious diseases 1992;24(3):309-15.